Capital Fund Management S.A. Novo Cure LTD Put Options Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $324,162 - $451,269	-26,100 Reduced 52.62%	23,500 $367,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $552,048 - $782,688	49,600 New	49,600 $740,000
Q4 2019 Feb 13, 2020	SELL	$68.3 - $93.8 $1.15 Million - $1.58 Million	-16,800 Reduced 85.71%	2,800 $236,000
Q3 2019 Nov 13, 2019	BUY	$61.86 - $97.8 $463,950 - $733,500	7,500 Added 61.98%	19,600 $1.47 Million
Q2 2019 Aug 12, 2019	BUY	$42.22 - $63.23 $510,862 - $765,083	12,100 New	12,100 $765,000

290

75.2M

1.81M

464K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.36B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.